Início › Câncer de Próstata › Carolina do Norte

Ensaios clínicos de Câncer de Próstata em Carolina do Norte

47 estudos para Câncer de Próstata estão buscando participantes em locais em Carolina do Norte.

Cidades em Carolina do Norte

Texto oficial do estudo (Inglês)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Durham VA Medical Center, Durham
Duke University Medical Center, Durham
FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
e mais 6

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Margaret R Pardee Memorial Hospital, Hendersonville

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Atrium Health Levine Cancer Institute, Charlotte

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 28 de set. de 2026 · NCT06095089

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Duke University Medical Center, Durham

RecrutandoFase 1/2

Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06800313

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Duke Cancer Center Cary, Cary
Duke University Medical Center (location of scans), Durham
Duke University Medical Center - Duke Cancer Center, Durham
e mais 5

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07028853

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Durham VA Medical Center, Durham, NC, Durham
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Durham VA Medical Center, Durham, NC, Durham

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT04038502

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Duke University Medical Center, Durham

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT07493512

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Associated Urologists of North Carolina (AUNC), Raleigh

Recrutando

Idades 18 e acima · Homens · Atualizado em 14 de set. de 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Duke University Medical Center, Durham

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Durham VA Medical Center, Durham
CarolinaEast Medical Center, New Bern

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Urology Specialists of the Carolinas - University Place, Charlotte

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 3 de set. de 2026 · NCT07723248

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

Duke University, Durham

RecrutandoEstudo observacional

Idades 18 e acima · Homens · Atualizado em 27 de ago. de 2026 · NCT07050433

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Levine Cancer Institute, Charlotte

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 24 de ago. de 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Duke University Medical Center, Durham

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 21 de ago. de 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Duke University medical center, Durham

RecrutandoFase 1/2

Idades 18 e acima · Homens · Atualizado em 20 de ago. de 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

ECU Health Oncology Kinston, Kinston

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Duke University Medical Center - Duke Cancer Center, Durham

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de ago. de 2026 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Duke University, Durham

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Duke Cancer Institute, Durham

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 10 de ago. de 2026 · NCT06067841

A Study of DM002 in Patients With Advanced Solid Tumors

Carolina BioOncology Institute, LLC, Huntersville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06751329

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

Duke University, Durham

RecrutandoEstudo observacional

Idades 40 e acima · Homens · Atualizado em 6 de ago. de 2026 · NCT07144228

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Atrium Health University City/LCI-University, Charlotte
Levine Cancer Institute-Ballantyne, Charlotte
e mais 9

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Wake Forest University Health Sciences, Winston-Salem

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Duke Cancer Center, Durham

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Levine Cancer Institute, Charlotte

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Duke University, Durham

RecrutandoFase 1/2

Idades 18 e acima · Homens · Atualizado em 25 de jun. de 2026 · NCT06457919

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT07463833

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

W.G. Bill Hefner Medical Center, Salisbury

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 15 de jun. de 2026 · NCT05422911

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Duke University Medical Center, Durham

RecrutandoFase 4

Idades de 18 a 100 · Homens · Atualizado em 4 de jun. de 2026 · NCT05803941

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

University of North Carolina at Chapel Hill, Chapel Hill
Durham VA Medical Center, Durham
Duke Cancer Network, Durham
e mais 1

RecrutandoEstudo observacional

Idades 21 e acima · Homens · Atualizado em 22 de mai. de 2026 · NCT03151629

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

W.G. Bill Hefner VA Medical Center, Salisbury
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 13 de abr. de 2026 · NCT04337580

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Durham VA Medical Center, Durham, NC, Durham

RecrutandoFase 2/3

Idades 18 e acima · Homens · Atualizado em 8 de abr. de 2026 · NCT04787744

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.